Dimensional Fund Advisors’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History

Dimensional Fund Advisors’s Portfolio CNST Stock Details CNST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-62,522	Closed	-$2.11M	–	3580
2021 Q2	$2.11M	Buy	+62,522	New	+$1.59M	﹤0.01%	2859
2020 Q4	–	Sell	-10,520	Closed	-$213K	–	3373
2020 Q3	$213K	Hold	10,520	–	–	﹤0.01%	3196
2020 Q2	$316K	Sell	10,520 -24,498	-70%	-$882K	﹤0.01%	3154
2020 Q1	$1.1M	Hold	35,018	–	–	﹤0.01%	2872
2019 Q4	$1.65M	Buy	+35,018	New	+$1.01M	﹤0.01%	2903

Dimensional Fund Advisors's CNST Position: Q3 2021 in Review

Dimensional Fund Advisors sold out of Constellation Pharmaceuticals, Inc. (CNST) in Q3 2021, closing a stake of 62,522 shares — an estimated $2.11M sold.

Dimensional Fund Advisors first reported a position in CNST in Q4 2019 and held it in 5 quarters. The position peaked at $2.11M in Q2 2021. 0 funds tracked by Wall St. Rank hold CNST as of Q3 2021.

Dimensional Fund Advisors reported no remaining Constellation Pharmaceuticals, Inc. position as of Q3 2021 after selling out during the quarter.
Dimensional Fund Advisors sold 62,522 Constellation Pharmaceuticals, Inc. shares in Q3 2021, an estimated $2.11M.
Dimensional Fund Advisors first reported a position in Constellation Pharmaceuticals, Inc. in Q4 2019 and held it in 5 quarters.
Dimensional Fund Advisors's Constellation Pharmaceuticals, Inc. position peaked at $2.11M in Q2 2021.
0 funds tracked by Wall St. Rank held Constellation Pharmaceuticals, Inc. as of Q3 2021.

Based on Dimensional Fund Advisors's 13F filing for Q3 2021, filed 12 Nov 2021.